Ingrid Delaet
General Counsel at NEUROCRINE BIOSCIENCES, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Ingrid Delaet is currently the Chief Regulatory Officer at Neurocrine Biosciences, Inc. She previously worked as the Senior Vice President-Regulatory Affairs at Intercept Pharmaceuticals, Inc. from 2016 to 2021.
Dr. Delaet holds graduate and doctorate degrees from Université Libre de Bruxelles.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 7,507 ( 0.01% ) | 1 M $ | 2024-03-30 |
Ingrid Delaet active positions
| Companies | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | General Counsel | 2020-12-31 |
Former positions of Ingrid Delaet
| Companies | Position | End |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | General Counsel | 2020-12-31 |
Training of Ingrid Delaet
| Université Libre de Bruxelles | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Ingrid Delaet
